Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Thiel-backed CEO eyes $50M fundraise after bagging China drug
Ashlins Pharma has licensed a Chinese formulation of a well-known medicine and set its sights on a $50 million fundraise.
Darren Incorvaia
Jul 22, 2026 4:00am
De-risking rare disease launches: precision beats scale
Brought to you by
PANTHERx® Rare Pharmacy
NIH joins Trump’s $5B AI mission with biomedical research push
Jul 22, 2026 2:43pm
Understanding Agentic AI in Clinical Development
Brought to you by
Syneos Health
House passes bill directing FDA to update animal testing rules
Jul 22, 2026 10:55am
Royalty pens $425M deal for slice of AstraZeneca ATTR drug sales
Jul 22, 2026 10:01am
More News
Biotech leaders back FDA against ‘malicious’ abortion lawsuit
Jul 22, 2026 9:00am
Crystalys mines $130M series B to push gout drug through phase 3
Jul 22, 2026 8:00am
Celldex ends skin disease program after failing phase 2 test
Jul 22, 2026 6:00am
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
Jul 21, 2026 1:26pm
See more stories